Moderna, Inc.
MRNA
$49.04
-$0.99-1.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -45.51% | -33.61% | |||
| Total Other Revenue | 15.63% | -25.58% | |||
| Total Revenue | -42.63% | -33.27% | |||
| Cost of Revenue | -40.83% | 21.73% | |||
| Gross Profit | 38.62% | -6,962.50% | |||
| SG&A Expenses | -43.83% | 14.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -41.43% | 20.30% | |||
| Operating Income | 40.49% | -229.62% | |||
| Income Before Tax | -66.96% | -327.27% | |||
| Income Tax Expenses | -66.67% | 107.69% | |||
| Earnings from Continuing Operations | -62.59% | -313.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -62.59% | -313.00% | |||
| EBIT | 40.49% | -229.62% | |||
| EBITDA | 42.91% | -279.81% | |||
| EPS Basic | -61.36% | -310.90% | |||
| Normalized Basic EPS | 43.35% | -315.13% | |||
| EPS Diluted | -61.36% | -310.90% | |||
| Normalized Diluted EPS | 43.35% | -315.13% | |||
| Average Basic Shares Outstanding | 0.77% | 0.51% | |||
| Average Diluted Shares Outstanding | 0.77% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||